Complement use of Chinese herbal medicine after percutaneous coronary intervention: a prospective observational study.

Journal of geriatric cardiology : JGC(2022)

Cited 0|Views4
No score
Abstract
For CAD patients after PCI treatment, complement use of Chinese herbal medicine is associated with a lower 2-year MACE incidence. Randomized prospective studies are warranted to provide higher levels of benefit evidence in these patients.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined